Xa因子抑制剂在预防癌症相关静脉血栓栓塞中的应用：临床试验的经验教训 - Suppr

Factor Xa inhibitors in the prevention of cancer-related venous thromboembolism: lessons learned by clinical trials.

作者信息

Lavalle Carlo, V Mariani Marco, Fedele Francesco

机构信息

Department of Clinical, Internal Medicine, Anesthesiology & Cardiovascular Sciences, Sapienza University of Rome, 00161 Rome, Italy.

出版信息

Future Oncol. 2020 Nov;16(32):2591-2594. doi: 10.2217/fon-2020-0696. Epub 2020 Aug 17.

DOI:10.2217/fon-2020-0696

PMID:32805155

Abstract

摘要

相似文献

Factor Xa inhibitors in the prevention of cancer-related venous thromboembolism: lessons learned by clinical trials.Xa因子抑制剂在预防癌症相关静脉血栓栓塞中的应用：临床试验的经验教训

Future Oncol. 2020 Nov;16(32):2591-2594. doi: 10.2217/fon-2020-0696. Epub 2020 Aug 17.

Patient satisfaction after conversion from warfarin to direct oral anticoagulants for patients on extended duration of anticoagulation for venous thromboembolism - The SWAN Study.静脉血栓栓塞症抗凝延长治疗患者换用直接口服抗凝剂后对患者满意度的影响：SWAN 研究。

PLoS One. 2020 Jun 4;15(6):e0234048. doi: 10.1371/journal.pone.0234048. eCollection 2020.

[Not Available].[无可用内容]

Lakartidningen. 2018 Dec 4;115:FAS3.

Are direct oral anticoagulants an economically attractive alternative to low molecular weight heparins in lung cancer associated venous thromboembolism management?直接口服抗凝剂在肺癌相关静脉血栓栓塞症管理中作为低分子肝素的经济吸引力替代物？

J Thromb Thrombolysis. 2020 Oct;50(3):642-651. doi: 10.1007/s11239-020-02047-1.

Treatment of Venous Thromboembolism in Cancer. Historical Perspective and Evolving Role of the Direct Oral Anticoagulants.癌症患者静脉血栓栓塞的治疗。直接口服抗凝剂的历史回顾与作用演变

Cancer Treat Res. 2019;179:103-115. doi: 10.1007/978-3-030-20315-3_7.

Can I use direct oral anticoagulants to treat cancer-associated venous thromboembolism?我可以使用直接口服抗凝剂治疗癌症相关的静脉血栓栓塞症吗？

Cleve Clin J Med. 2020 Apr;87(4):201-203. doi: 10.3949/ccjm.87a.19100.

Direct Oral Anticoagulants for the Treatment of Acute Venous Thromboembolism Associated with Cancer: A Systematic Review and Meta-Analysis.直接口服抗凝剂治疗伴癌急性静脉血栓栓塞症：系统评价和荟萃分析。

Thromb Haemost. 2020 Jul;120(7):1128-1136. doi: 10.1055/s-0040-1712098. Epub 2020 May 4.

Evaluation of direct oral anticoagulants for the treatment of cancer-associated thrombosis: an update.评估直接口服抗凝剂治疗癌症相关性血栓：更新。

J Thromb Thrombolysis. 2019 Apr;47(3):409-419. doi: 10.1007/s11239-018-1783-2.

Direct oral anticoagulants for the treatment and prevention of venous thromboembolism in patients with cancer: current evidence.直接口服抗凝剂治疗和预防癌症患者静脉血栓栓塞症：当前证据。

Clin Transl Oncol. 2021 Jun;23(6):1034-1046. doi: 10.1007/s12094-020-02506-4. Epub 2020 Nov 18.

Comparing Direct Oral Anticoagulants and Warfarin for Atrial Fibrillation, Venous Thromboembolism, and Mechanical Heart Valves.比较直接口服抗凝剂与华法林用于心房颤动、静脉血栓栓塞和机械心脏瓣膜的情况。

Consult Pharm. 2015 Nov;30(11):644-56. doi: 10.4140/TCP.n.2015.644.

引用本文的文献

Five Years of Direct Oral Anticoagulants Use in Italy: Adverse Drug Reactions from the Italian National Pharmacovigilance Network.意大利直接口服抗凝剂五年使用情况：来自意大利国家药物警戒网络的药物不良反应

J Clin Med. 2022 Jun 4;11(11):3207. doi: 10.3390/jcm11113207.

Direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation and cancer a meta-analysis.直接口服抗凝剂与维生素 K 拮抗剂在伴有房颤和癌症患者中的应用：一项荟萃分析。

J Thromb Thrombolysis. 2021 Feb;51(2):419-429. doi: 10.1007/s11239-020-02304-3. Epub 2020 Oct 12.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Factor Xa inhibitors in the prevention of cancer-related venous thromboembolism: lessons learned by clinical trials.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献

引用本文的文献